SCHEMBL22111682

SCHEMBL22111682

COC(=O)CNC=C1C(=O)CC(c2ccccc2)CC1=O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAP1LC3B Q9GZQ8 7/20 0.49
▸ KMT2A Q03164 6/20 0.46
▸ MEN1 O00255 5/20 0.46
▸ LMNA P02545 4/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ AKR1C2 P52895 1/20 0.41
▸ AKR1C1 Q04828 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ HTT P42858 3/20 0.39
▸ HPGD P15428 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22056789 0.86 MAP1LC3B (0.50) MAP1LC3BKMT2AMEN1RAB9AAKR1C2
SCHEMBL21821667 0.81 MAP1LC3B (0.45) MAP1LC3BKMT2AMEN1AKR1C2AKR1C1
SCHEMBL21821830 0.80 MAP1LC3B (0.47) MAP1LC3BKMT2AMEN1RAB9AAKR1C2
SCHEMBL21821579 0.80 MAP1LC3B (0.50) MAP1LC3BKMT2AMEN1LMNARAB9A
SCHEMBL21821807 0.78 MAP1LC3B (0.48) MAP1LC3BKMT2AMEN1LMNARAB9A
SCHEMBL22056808 0.78 MAP1LC3B (0.50) MAP1LC3BKMT2AMEN1RAB9AAKR1C2
SCHEMBL21821905 0.77 MAP1LC3B (0.56) MAP1LC3BKMT2AMEN1LMNARAB9A
SCHEMBL22111685 0.77 MAP1LC3B (0.52) MAP1LC3BKMT2AMEN1LMNARAB9A
SCHEMBL22056928 0.76 MAP1LC3B (0.51) MAP1LC3BKMT2AMEN1AKR1C2AKR1C1
SCHEMBL22056782 0.75 MAP1LC3B (0.57) MAP1LC3BKMT2AMEN1AKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632903-B1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN) 2023-10-11 — — EP disclosed
EP-3632903-B1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN) 2023-10-11 — — EP disclosed
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2022-05-03 — — US disclosed
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2022-05-03 — — US disclosed
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2020-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof ATG7, SQSTM1, BECN1 MAP1LC3B 15/4885KMT2A 3378/4885MEN1 3447/4885
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF ATG7, SQSTM1, BECN1 MAP1LC3B 15/4885KMT2A 3378/4885MEN1 3447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback